Investigating the physicochemical properties of solid dispersions based on semicrystalline carriers: A case study with ketoprofen.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
05 Feb 2023
Historique:
received: 06 09 2022
revised: 28 12 2022
accepted: 29 12 2022
pubmed: 4 1 2023
medline: 14 3 2023
entrez: 3 1 2023
Statut: ppublish

Résumé

Hydrophilic semicrystalline carriers represent an alternative to amorphous polymers due to their low melting temperature, useful for the production of solid dispersions (SDs) by melting-based technologies. This research aims to compare SDs of ketoprofen (KET) and three different semicrystalline carriers (PEG, Poloxamer and Gelucire) regarding miscibility, phase behavior, molecular interactions and stability. KET was chosen owing to its low solubility and high glass forming ability. Estimation of drug-excipient miscibility was performed by Flory-Huggins theory. Negative Gibbs free energy indicated a spontaneous mixing of KET with the three carriers and miscibility in the order PEG > Poloxamer > Gelucire. SDs up to 40 % w/w of drug were produced by melting process at a temperature below KET melting point. Characterization of SDs was performed by differential scanning calorimetry, polarized light microscopy and powder X-ray diffraction. In case of PEG and Poloxamer, the drug incorporation did not affect carrier crystallinity, while KET was in the amorphous state. Differently, KET retarded the crystallization of Gelucire and at high drug loadings the SDs were amorphous and semisolid. FT-IR analysis revealed a strong interaction between KET and the three carriers. Finally, PEG-based SDs above 20 % KET loading displayed drug crystallization after 6 months of storage; while Poloxamer and Gelucire-based SDs showed KET crystallization only at 40 % KET. Due to its less hydrophilic character and limited water uptake, Gelucire showed the best stability among the three excipients.

Identifiants

pubmed: 36596317
pii: S0378-5173(22)01131-0
doi: 10.1016/j.ijpharm.2022.122576
pii:
doi:

Substances chimiques

Polyethylene Glycols 3WJQ0SDW1A
Poloxamer 106392-12-5
Ketoprofen 90Y4QC304K
Polymers 0
Excipients 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122576

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Serena Bertoni (S)

Department of Pharmacy and BioTechnology, PharmTech Lab, Alma Mater Studiorum-University of Bologna, Via S. Donato 19/2, 40127 Bologna, Italy.

Beatrice Albertini (B)

Department of Pharmacy and BioTechnology, PharmTech Lab, Alma Mater Studiorum-University of Bologna, Via S. Donato 19/2, 40127 Bologna, Italy.

Nadia Passerini (N)

Department of Pharmacy and BioTechnology, PharmTech Lab, Alma Mater Studiorum-University of Bologna, Via S. Donato 19/2, 40127 Bologna, Italy. Electronic address: nadia.passerini@unibo.it.

Articles similaires

Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
Animals Huntington Disease Mitochondria Neurons Mice
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis

Classifications MeSH